Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $3.4M, listed on NASDAQ, employing roughly 5 people, carrying a beta of 0.00 to the broader market. Lakewood-Amedex Biotherapeutics, Inc. Led by Kelvin Cooper, public since 2026-04-23.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for LABT as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →